You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Advanced Renal Cell Carcinoma

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Urine Omics Predicting IO Therapy Responses in mRCC Patients

Recruiting
  • Metastatic Renal Cell Carcinoma
  • No intervention required
  • Taipei, Taiwan
    National Taiwan University Hospital
Jan 18, 2022

Tumors, Kidney Tumors, Urologic Tumors Trial in Nanjing (Toripalimab, Axitinib, Lenvatinib)

Recruiting
  • Neoplasms
  • +12 more
  • Nanjing, Jiangsu, China
    Jinling Hospital, Affiliated Hospital of Medical School, Nanjing
Oct 28, 2023

Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Trial

Recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • +3 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Dec 2, 2022

Advanced Cancer, Clear Cell Renal Cell Carcinoma Trial in Houston (177Lu girentuximab, Nivolumab, Cabozantinib)

Not yet recruiting
  • Advanced Cancer
  • Clear Cell Renal Cell Carcinoma
  • 177Lu girentuximab
  • +3 more
  • Houston, Texas
    MD Anderson Cancer Center
Dec 15, 2022

Renal Cell Carcinoma Trial (Pembrolizumab)

Completed
Has Results
  • Renal Cell Carcinoma
  • Pembrolizumab
  • (no location specified)
Aug 17, 2022

NSCLC, Renal Cell Carcinoma, Squamous Cell Carcinoma of the Head and Neck Trial in Duarte (JANX008)

Recruiting
  • Non-Small Cell Lung Cancer
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Mar 29, 2023

Clear Cell Renal Cell Carcinoma, Kidney Cancer, Advanced Renal Cell Carcinoma Trial in United States

Recruiting
  • Clear Cell Renal Cell Carcinoma
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Feb 16, 2022

Renal Cancer Trial in New York (Magnetic Resonance Imaging (MRI) Scan, Tc-99m Pentetate)

Recruiting
  • Renal Cancer
  • Magnetic Resonance Imaging (MRI) Scan
  • Tc-99m Pentetate
  • New York, New York
    NYU Langone Health
Oct 31, 2023

Advanced Renal Cell Carcinoma Trial in United States (Dalantercept and axitinib, Placebo and axitinib)

Terminated
Has Results
  • Advanced Renal Cell Carcinoma
  • Dalantercept and axitinib
  • Placebo and axitinib
  • Tucson, Arizona
  • +35 more
Sep 12, 2022

Clear Cell Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Metastatic Trial in Iowa City (Selenomethionine (SLM),

Recruiting
  • Clear Cell Renal Cell Carcinoma
  • Clear Cell Renal Cell Carcinoma Metastatic
  • Selenomethionine (SLM)
  • +2 more
  • Iowa City, Iowa
    University of Iowa Hospitals & Clinics
Sep 19, 2022

Advanced Cancer, Advanced Malignancies, Bladder Cancer Trial (AB598, Zimberelimab, Carboplatin)

Not yet recruiting
  • Advanced Cancer
  • +11 more
  • (no location specified)
May 26, 2023

Advanced Solid Tumor, CDKN2A, NSCLC Trial (Milademetan, Atezolizumab)

Withdrawn
  • Advanced Solid Tumor
  • +9 more
  • (no location specified)
Oct 16, 2023

Clear-cell Metastatic Renal Cell Carcinoma Trial in Guangzhou (Drug: Pembrolizumab)

Not yet recruiting
  • Clear-cell Metastatic Renal Cell Carcinoma
  • Drug: Pembrolizumab
  • Guangzhou, Guangdong, China
  • +1 more
Oct 7, 2022

NSCLC, Carcinoma, Renal Cell, Esophageal Squamous Cell Carcinoma Trial (QEQ278)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +3 more
  • QEQ278
  • (no location specified)
Jul 14, 2022

Advanced Renal Cell Carcinoma, Chromophobe Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Trial in United States (drug,

Recruiting
  • Advanced Renal Cell Carcinoma
  • +8 more
  • Cabozantinib S-malate
  • +3 more
  • Birmingham, Alabama
  • +35 more
Jan 24, 2023

Melanoma, Urothelial Carcinoma, Renal Cell Carcinoma Trial in Auchenflower (RC198 Injection)

Not yet recruiting
  • Melanoma
  • +5 more
  • RC198 Injection
  • Auchenflower, Queensland, Australia
    Research Site
May 17, 2023

Advanced Renal Cell Carcinoma Trial in United States (Nivolumab 240 mg, Ipilimumab 1mg/kg, Nivolumab 3mg/kg)

Recruiting
  • Advanced Renal Cell Carcinoma
  • Nivolumab 240 mg
  • +3 more
  • New Haven, Connecticut
  • +11 more
Feb 14, 2022

Cabozantinib in Combination With Nivolumab as First-line

Recruiting
  • Advanced Renal Cell Carcinoma
    • Angers, France
    • +42 more
    Dec 1, 2022

    Carcinoma, Renal Cell, NSCLC Trial in Belgium, France (Live Bacterial Product - Akkermansia muciniphila)

    Recruiting
    • Carcinoma, Renal Cell
    • Carcinoma, Non-Small-Cell Lung
    • Live Bacterial Product - Akkermansia muciniphila
    • Mons, Belgium
    • +3 more
    May 9, 2023

    Advanced Clear Cell Renal Cell Carcinoma Trial (6MW3211)

    Not yet recruiting
    • Advanced Clear Cell Renal Cell Carcinoma
    • (no location specified)
    Aug 14, 2022

    Solid Tumors With HRAS Alterations, Non Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC) Trial (KO-2806, Cabozantinib)

    Not yet recruiting
    • Solid Tumors With HRAS Alterations
    • +4 more
    • (no location specified)
    Aug 30, 2023

    Metastatic Tumor, Renal Cell Carcinoma, Advanced Cancer Trial in Jinan (CD70 CAR-T cells)

    Recruiting
    • Metastatic Tumor
    • +2 more
    • CD70 CAR-T cells
    • Jinan, Shandong, China
      The Second People's Hospital of Shandong Province
    Jun 26, 2022

    Metastatic Melanoma, Advanced Locoregional Melanoma, Metastatic Renal Cell Carcinoma Trial run by the National Cancer Institute

    Recruiting
    • Metastatic Melanoma
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 20, 2022

    Metastatic Renal Cell Carcinoma, Kidney Cancer, Kidney Tumor Trial in Herlev (Electronic patient-reported outcomes regarding

    Not yet recruiting
    • Metastatic Renal Cell Carcinoma
    • +5 more
    • Electronic patient-reported outcomes regarding symptoms and health-related quality of life
    • Herlev, Denmark
      Department of Oncology, Herlev and Gentofte Hospital
    Nov 15, 2021

    Advanced Clear Cell Renal Cell Carcinoma Trial in Boston (Axitinib, Palbociclib, Avelumab)

    Not yet recruiting
    • Advanced Clear Cell Renal Cell Carcinoma
    • Boston, Massachusetts
    • +2 more
    Jun 27, 2022